RICARDO FERMO: Open Payments
NPI 1386752236 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,444 in 104 payments from 12 companies in 2025. Trend: 2023 $60,264 · 2024 $78,470 · 2025 $65,444
Honoraria: $42,950Speaker / faculty: $13,430Travel & lodging: $4,701Food & beverage: $2,443Consulting: $1,920
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 48 | $48,805 |
| Alkermes, Inc. | 17 | $12,200 |
| ABBVIE INC. | 21 | $3,862 |
| Janssen Pharmaceuticals, Inc | 3 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Corium, LLC | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: Auvelity, LYBALVI, VRAYLAR, SPRAVATO, ARISTADA, TRINTELLIX, UBRELVY, Azstarys.
Industry payments across SC — which companies pay providers there.
